奥泰生物
(688606)
| 流通市值：34.59亿 | | | 总市值：34.59亿 |
| 流通股本：7565.44万 | | | 总股本：7565.44万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,847,967,875.13 | 1,748,017,537.21 | 1,067,266,075.69 | 984,395,729.24 |
| 交易性金融资产 | 276,186,261.64 | 488,175,292.59 | 1,324,890,081.11 | 1,474,239,693.39 |
| 应收票据及应收账款 | 145,117,261.47 | 151,319,226.88 | 159,047,825.16 | 166,099,916.85 |
| 应收账款 | 145,117,261.47 | 151,319,226.88 | 159,047,825.16 | 166,099,916.85 |
| 预付款项 | 13,066,554.38 | 14,134,051.98 | 14,129,812.12 | 23,463,824.07 |
| 其他应收款合计 | 8,684,803.56 | 6,379,394.69 | 5,979,081.69 | 5,985,528.48 |
| 存货 | 192,494,033.82 | 184,958,305.92 | 176,689,306.84 | 180,710,380.01 |
| 其他流动资产 | 84,161,121.51 | 99,022,252.36 | 83,757,355.81 | 92,750,282.42 |
| 流动资产合计 | 2,567,677,911.51 | 2,692,006,061.63 | 2,831,759,538.42 | 2,927,645,354.46 |
| 非流动资产: | | | | |
| 长期股权投资 | 98,400,797.52 | 98,728,243.73 | 98,728,243.73 | 81,367,856.18 |
| 其他权益工具投资 | 24,750,356.6 | 17,847,856.6 | 17,847,856.6 | 17,847,856.6 |
| 其他非流动金融资产 | 18,000,000 | 18,000,000 | 18,000,000 | 18,000,000 |
| 投资性房地产 | 74,740,675.49 | 68,083,848.7 | 61,919,957.58 | 54,351,788.94 |
| 固定资产 | 970,728,665.42 | 983,851,573.19 | 994,456,083.7 | 421,703,815.01 |
| 在建工程 | 39,001,920.92 | 32,755,706.4 | 15,336,809.11 | 520,475,291.52 |
| 使用权资产 | 6,947,594.01 | 7,530,298.67 | 7,889,108.04 | 8,338,746.28 |
| 无形资产 | 133,919,356.19 | 135,292,842.15 | 136,818,845.76 | 138,271,522.31 |
| 长期待摊费用 | 19,238,185.31 | 14,906,646.8 | 16,490,866.54 | 9,652,538.55 |
| 递延所得税资产 | 21,782,561.97 | 20,163,260.04 | 22,049,411.3 | 22,987,203.13 |
| 其他非流动资产 | 22,175,845.5 | 19,890,020.33 | 21,128,239.89 | 21,384,365.44 |
| 非流动资产合计 | 1,429,685,958.93 | 1,417,050,296.61 | 1,410,665,422.25 | 1,314,380,983.96 |
| 资产总计 | 3,997,363,870.44 | 4,109,056,358.24 | 4,242,424,960.67 | 4,242,026,338.42 |
| 流动负债: | | | | |
| 交易性金融负债 | 12,145,021 | 12,762,464 | 19,809,014 | 28,497,627 |
| 应付票据及应付账款 | 82,299,803.67 | 79,190,569.98 | 120,045,617.81 | 67,440,960.59 |
| 应付账款 | 82,299,803.67 | 79,190,569.98 | 120,045,617.81 | 67,440,960.59 |
| 预收款项 | 2,055,784.1 | 1,768,372.46 | 872,190.32 | 448,272.8 |
| 合同负债 | 39,250,193.85 | 33,576,711.41 | 35,023,065.15 | 41,142,999.8 |
| 应付职工薪酬 | 16,563,758.2 | 11,801,513.7 | 26,067,168.25 | 19,188,365.95 |
| 应交税费 | 74,207,474.06 | 77,039,968.19 | 83,056,346.73 | 92,167,955.54 |
| 其他应付款合计 | 1,421,941.02 | 690,899.18 | 910,334.89 | 79,877,670.2 |
| 应付股利 | - | - | - | 78,307,224 |
| 一年内到期的非流动负债 | 868,962.89 | 536,194.82 | 544,672.4 | 289,510.54 |
| 其他流动负债 | 530,034.75 | 468,091.32 | 316,151.15 | 488,046.86 |
| 流动负债合计 | 229,342,973.54 | 217,834,785.06 | 286,644,560.7 | 329,541,409.28 |
| 非流动负债: | | | | |
| 租赁负债 | 6,162,637.11 | 6,814,590.88 | 6,867,318.1 | 7,959,784.17 |
| 递延收益 | 1,710,421.91 | 2,142,280.08 | 2,574,138.25 | 3,166,384.75 |
| 递延所得税负债 | - | - | - | 11,274.11 |
| 非流动负债合计 | 7,873,059.02 | 8,956,870.96 | 9,441,456.35 | 11,137,443.03 |
| 负债合计 | 237,216,032.56 | 226,791,656.02 | 296,086,017.05 | 340,678,852.31 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 79,280,855 | 79,280,855 | 79,280,855 | 79,280,855 |
| 资本公积 | 1,685,190,409.78 | 1,682,769,443.67 | 1,680,354,501.42 | 1,696,590,330.09 |
| 减:库存股 | 212,421,258.46 | 133,309,975.09 | 47,406,740.77 | 77,897,481.18 |
| 其他综合收益 | 32,556,215.97 | 32,460,679.15 | 32,169,058.37 | 31,889,034.24 |
| 盈余公积 | 266,191,150.02 | 266,191,150.02 | 266,191,150.02 | 266,191,150.02 |
| 未分配利润 | 1,909,930,436.61 | 1,955,496,487.63 | 1,936,102,142.3 | 1,905,719,944.46 |
| 归属于母公司股东权益合计 | 3,760,727,808.92 | 3,882,888,640.38 | 3,946,690,966.34 | 3,901,773,832.63 |
| 少数股东权益 | -579,971.04 | -623,938.16 | -352,022.72 | -426,346.52 |
| 股东权益合计 | 3,760,147,837.88 | 3,882,264,702.22 | 3,946,338,943.62 | 3,901,347,486.11 |
| 负债和股东权益合计 | 3,997,363,870.44 | 4,109,056,358.24 | 4,242,424,960.67 | 4,242,026,338.42 |
| 公告日期 | 2026-08-29 | 2026-04-20 | 2026-04-20 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |